Drug Therapy for Vagally-Mediated Atrial Fibrillation and Sympatho-Vagal Balance in the Genesis of Atrial Fibrillation: A Review of the Current Literature
Journal of Atrial Fibrillation · 2020-06 · 13 (1)
DOI: 10.4022/jafib.2410 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Atrial Fibrillation, online erschienen am 30.06.2020. Verfasst von Pattara Rattanawong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ, USA. Die Arbeit wurde bisher 13-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, AZ, USA.
- University of Hawaii Internal Medicine Residency Program, Honolulu, HI, USA.
Zitieren
APA
Rattanawong, P., Kewcharoen, J., S Srivathsan, K., & Shen, W. K. (2020). Drug Therapy for Vagally-Mediated Atrial Fibrillation and Sympatho-Vagal Balance in the Genesis of Atrial Fibrillation: A Review of the Current Literature. Journal of Atrial Fibrillation, 13(1). https://doi.org/10.4022/jafib.2410
Vancouver
Rattanawong P, Kewcharoen J, S Srivathsan K, Shen WK. Drug Therapy for Vagally-Mediated Atrial Fibrillation and Sympatho-Vagal Balance in the Genesis of Atrial Fibrillation: A Review of the Current Literature. Journal of Atrial Fibrillation. 2020;13(1). doi:10.4022/jafib.2410
BibTeX
@article{Rattanawong2020,
author = {Rattanawong, Pattara and Kewcharoen, Jakrin and S Srivathsan, Komandoor and Shen, Win-Kuang},
title = {Drug Therapy for Vagally-Mediated Atrial Fibrillation and Sympatho-Vagal Balance in the Genesis of Atrial Fibrillation: A Review of the Current Literature},
journal = {Journal of Atrial Fibrillation},
year = {2020},
volume = {13},
number = {1},
doi = {10.4022/jafib.2410}
}
EUVIMED